General Information of Drug (ID: DM2GJZE)

Drug Name
2-amino-3-(m-tolylamino)naphthalene-1,4-dione
Synonyms CHEMBL598551; 2-amino-3-(m-tolylamino)naphthalene-1,4-dione; MolPort-007-563-584; ZINC27548840; BDBM50306786; AKOS001660486; MCULE-4833073664; EU-0076855
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 278.3
Logarithm of the Partition Coefficient (xlogp) 3.1
Rotatable Bond Count (rotbonds) 2
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 4
Chemical Identifiers
Formula
C17H14N2O2
IUPAC Name
2-amino-3-(3-methylanilino)naphthalene-1,4-dione
Canonical SMILES
CC1=CC(=CC=C1)NC2=C(C(=O)C3=CC=CC=C3C2=O)N
InChI
InChI=1S/C17H14N2O2/c1-10-5-4-6-11(9-10)19-15-14(18)16(20)12-7-2-3-8-13(12)17(15)21/h2-9,19H,18H2,1H3
InChIKey
REWOWOXSGLQOHC-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
11976150
TTD ID
D06PYV

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Adenosine A2a receptor (ADORA2A) TTM2AOE AA2AR_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists. J Med Chem. 2010 Feb 25;53(4):1799-809.